The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren’s syndrome
Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Me...
Saved in:
Published in | Arthritis research & therapy Vol. 24; no. 1; pp. 1 - 13 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
19.07.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Methods pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. Results NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-[alpha] 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Conclusions Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs. Keywords: Primary Sjögren's syndrome, Neutrophils, Neutrophil extracellular traps, Type I interferon, Mitochondrial damage |
---|---|
AbstractList | Abstract Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren’s syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Methods pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. Results NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-α 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Conclusions Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs. Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-[alpha] 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs. Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS.OBJECTIVENeutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS.pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry.METHODSpSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry.NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-α 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils.RESULTSNETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-α 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils.Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs.CONCLUSIONSOur data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs. Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Methods pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. Results NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-[alpha] 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Conclusions Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs. Keywords: Primary Sjögren's syndrome, Neutrophils, Neutrophil extracellular traps, Type I interferon, Mitochondrial damage Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren’s syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Methods pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. Results NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-α 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Conclusions Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs. |
ArticleNumber | 170 |
Audience | Academic |
Author | Deng, Chuiwen Peng, Linyi Wang, Anqi Wang, Mu Yang, Huaxia Chen, Yingying Fei, Yunyun Wu, Xunyao Zhang, Shulan Zhou, Jiaxin Luo, Xuan Peng, Yu Wu, Qingjun Xiao, Qiufeng Zeng, Xiaofeng Zhang, Wen Zhao, Yan Zhao, Lidan |
Author_xml | – sequence: 1 givenname: Yu surname: Peng fullname: Peng, Yu – sequence: 2 givenname: Xunyao surname: Wu fullname: Wu, Xunyao – sequence: 3 givenname: Shulan surname: Zhang fullname: Zhang, Shulan – sequence: 4 givenname: Chuiwen surname: Deng fullname: Deng, Chuiwen – sequence: 5 givenname: Lidan surname: Zhao fullname: Zhao, Lidan – sequence: 6 givenname: Mu surname: Wang fullname: Wang, Mu – sequence: 7 givenname: Qingjun surname: Wu fullname: Wu, Qingjun – sequence: 8 givenname: Huaxia surname: Yang fullname: Yang, Huaxia – sequence: 9 givenname: Jiaxin surname: Zhou fullname: Zhou, Jiaxin – sequence: 10 givenname: Linyi surname: Peng fullname: Peng, Linyi – sequence: 11 givenname: Xuan surname: Luo fullname: Luo, Xuan – sequence: 12 givenname: Yingying surname: Chen fullname: Chen, Yingying – sequence: 13 givenname: Anqi surname: Wang fullname: Wang, Anqi – sequence: 14 givenname: Qiufeng surname: Xiao fullname: Xiao, Qiufeng – sequence: 15 givenname: Wen surname: Zhang fullname: Zhang, Wen – sequence: 16 givenname: Yan surname: Zhao fullname: Zhao, Yan – sequence: 17 givenname: Xiaofeng surname: Zeng fullname: Zeng, Xiaofeng – sequence: 18 givenname: Yunyun surname: Fei fullname: Fei, Yunyun |
BookMark | eNp9UktuFDEQbaEg8oELsLLEJiw6-Nfd9gYpigKMFMGCsLbc7uoZj3rsxvZEzI5rsOAaXICbcBLcM4PIRAhZlsvlV68-fqfFkfMOiuI5wReEiPpVJAw3VYkpzVvUuOSPihPCG1HWrKZH9-zj4jTGJc5ISfmT4phVouKM0pPi--0C0OgTuGT1gIIfICLfo7QZAc2QdQlCD8E7pE2ydzpBhxysU_Djwg4RaXf_juBLCtrAMKwHHVC2x4jO31_fxpeZCqUpl04LPwcH0W4TjcGudNigj8ufP-YB3K-v3yKKG9cFv4KnxeNeDxGe7c-z4tOb69urd-XNh7ezq8ub0tS4TmXLGpFb01VrGOeCQl9xrAWXuXXdEiEAKJOyrmrCJceU667hVS9FL7uqEZKdFbMdb-f1Uu1LUl5btXX4MFc6JGsGUK02reRCSKIbzrLdklqKVtfU1EwSk7le77jGdbuCzuTJBj0ckB6-OLtQc3-nJJUVrUQmON8TBP95DTGplY3TTLUDv46K1pLihhLMM_TFA-jSr4PLo5pQhHHMcfUXNde5Aet6P33SRKouG4JFQyhmGXXxD1ReHaysycrrbfYfBIhdgAk-xgC9MjbpZP3Ulh0UwWqSqdrJVGXxqa1M1VQ3fRD6Zzz_CfoNryXtDQ |
CitedBy_id | crossref_primary_10_1016_j_it_2025_01_008 crossref_primary_10_1096_fj_202402514R crossref_primary_10_3389_fvets_2024_1509399 crossref_primary_10_1093_rheumatology_kead545 crossref_primary_10_1167_iovs_65_4_33 crossref_primary_10_1038_s41598_024_74705_w crossref_primary_10_3390_diagnostics14030258 crossref_primary_10_3389_fmicb_2023_1126896 crossref_primary_10_1016_j_biopha_2024_116885 crossref_primary_10_1136_rmdopen_2023_003559 crossref_primary_10_2147_IJGM_S504780 crossref_primary_10_3389_fimmu_2024_1421436 crossref_primary_10_1016_j_jtos_2023_09_012 crossref_primary_10_1016_j_cytogfr_2024_12_001 crossref_primary_10_1016_j_jdermsci_2024_05_002 crossref_primary_10_1097_BOR_0000000000000986 crossref_primary_10_1016_j_jep_2025_119391 crossref_primary_10_1111_exd_14913 crossref_primary_10_1016_j_jtauto_2025_100280 crossref_primary_10_3389_fimmu_2024_1408880 crossref_primary_10_1016_j_jhazmat_2023_131236 crossref_primary_10_1186_s12943_025_02249_2 crossref_primary_10_1016_j_jare_2024_03_015 crossref_primary_10_1016_j_bioactmat_2024_01_020 crossref_primary_10_3389_fimmu_2023_1207545 crossref_primary_10_1007_s12026_024_09453_0 crossref_primary_10_1016_j_heliyon_2024_e41342 crossref_primary_10_2147_JIR_S433110 crossref_primary_10_1007_s11926_023_01125_6 crossref_primary_10_1016_j_clim_2024_110334 crossref_primary_10_1016_j_heliyon_2024_e40577 crossref_primary_10_18596_jotcsa_1404431 crossref_primary_10_1016_j_jtos_2024_02_003 crossref_primary_10_1111_imm_13829 crossref_primary_10_1016_j_jaut_2024_103296 crossref_primary_10_1007_s11418_023_01702_0 crossref_primary_10_3389_fimmu_2023_1181761 crossref_primary_10_3389_fddsv_2024_1404103 crossref_primary_10_3899_jrheum_2022_0827 crossref_primary_10_1111_1756_185X_15350 |
Cites_doi | 10.1002/art.39818 10.1038/nm.4027 10.1016/j.tripleo.2008.09.015 10.1073/pnas.87.11.4115 10.1007/s00281-013-0375-7 10.1002/art.1780291105 10.1016/j.jaci.2017.10.030 10.1590/abd1806-4841.20175476 10.1002/art.39296 10.1093/rheumatology/kev217 10.1126/sciimmunol.aag3358 10.4049/jimmunol.1202388 10.1093/rheumatology/keaa016 10.1038/s41598-020-76701-2 10.1016/j.celrep.2014.06.044 10.1126/science.1092385 10.1038/nm.1959 10.1126/scitranslmed.3001180 10.1038/s41467-020-19412-6 10.1136/annrheumdis-2018-213746 10.1016/j.bbrc.2018.04.234 10.1038/s41467-019-09160-7 10.1111/jcmm.15321 10.4049/jimmunol.1100450 10.4330/wjc.v7.i12.829 10.1126/scitranslmed.3005580 10.1136/ard.61.6.554 10.1136/rmdopen-2014-000022 10.1038/s41420-021-00491-3 10.1016/S0167-5699(97)01087-6 10.1016/j.mito.2018.01.007 10.1136/annrheumdis-2019-216588 10.4049/jimmunol.0902199 10.1038/s41584-018-0039-z 10.1016/j.jaut.2019.01.003 10.4049/jimmunol.1100123 10.1084/jem.20100239 10.1038/nrrheum.2011.132 10.1016/S0140-6736(05)66990-5 10.1172/jci.insight.134189 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s). The Author(s) 2022 |
Copyright_xml | – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s). – notice: The Author(s) 2022 |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13075-022-02860-4 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_bacb948891a743cb9b1698ba62c6391c PMC9295258 A710871203 10_1186_s13075_022_02860_4 |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: ; grantid: 81971544; 82172343; 81971545 – fundername: ; grantid: pumch201911238 – fundername: ; grantid: 2020-I2M-C & T-A-002 |
GroupedDBID | --- .GJ 0R~ 23N 2WC 4.4 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ INH INR ITC KQ8 M1P O5R O5S O9- PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c606t-b378229a5bc34482ef540a849362ab188ee23996561494024ad745f98f9d57893 |
IEDL.DBID | DOA |
ISSN | 1478-6362 1478-6354 |
IngestDate | Wed Aug 27 01:29:43 EDT 2025 Thu Aug 21 18:42:11 EDT 2025 Fri Jul 11 01:53:44 EDT 2025 Fri Jul 25 22:53:26 EDT 2025 Tue Jun 17 21:30:11 EDT 2025 Tue Jun 10 20:19:48 EDT 2025 Tue Jul 01 04:00:59 EDT 2025 Thu Apr 24 23:08:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c606t-b378229a5bc34482ef540a849362ab188ee23996561494024ad745f98f9d57893 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/bacb948891a743cb9b1698ba62c6391c |
PMID | 35854322 |
PQID | 2691340405 |
PQPubID | 42876 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_bacb948891a743cb9b1698ba62c6391c pubmedcentral_primary_oai_pubmedcentral_nih_gov_9295258 proquest_miscellaneous_2692072104 proquest_journals_2691340405 gale_infotracmisc_A710871203 gale_infotracacademiconefile_A710871203 crossref_citationtrail_10_1186_s13075_022_02860_4 crossref_primary_10_1186_s13075_022_02860_4 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-07-19 |
PublicationDateYYYYMMDD | 2022-07-19 |
PublicationDate_xml | – month: 07 year: 2022 text: 2022-07-19 day: 19 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Arthritis research & therapy |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | F Su (2860_CR7) 2017; 92 D Azzouz (2860_CR17) 2021; 7 C Carmona-Rivera (2860_CR18) 2013; 35 RJ Falk (2860_CR8) 1990; 87 AN Rao (2860_CR41) 2015; 7 E Rivière (2860_CR31) 2020; 79 RI Fox (2860_CR13) 2005; 366 L Zheng (2860_CR16) 2009; 107 R Khandpur (2860_CR2) 2013; 5 K Kessenbrock (2860_CR23) 2009; 15 W Jin (2860_CR38) 2018; 501 Y Lu (2860_CR39) 2020; 24 P Mistry (2860_CR33) 2018; 77 C Vitali (2860_CR14) 2002; 61 F Apel (2860_CR4) 2018; 14 SW Edwards (2860_CR10) 1997; 18 P Li (2860_CR11) 2010; 207 2860_CR12 R Seror (2860_CR15) 2015; 1 2860_CR34 H Wang (2860_CR25) 2015; 67 Y Furumoto (2860_CR27) 2017; 69 C Lood (2860_CR37) 2016; 22 L Moreira-Teixeira (2860_CR28) 2020; 11 P López (2860_CR19) 2020; 59 N Marketos (2860_CR29) 2019; 37 Suppl 118(3) V Brinkmann (2860_CR6) 2004; 303 J Perdomo (2860_CR40) 2019; 10 AM Lin (2860_CR35) 2011; 187 E Gul (2860_CR20) 2018; 142 E Villanueva (2860_CR1) 2011; 187 KD Metzler (2860_CR5) 2014; 8 Y Peng (2860_CR30) 2020; 10 E Hacbarth (2860_CR32) 1986; 29 MF Denny (2860_CR36) 2010; 184 MJ Kaplan (2860_CR22) 2011; 7 D Söderberg (2860_CR3) 2015; 54 R Lande (2860_CR9) 2011; 3 M Ribon (2860_CR24) 2019; 98 K Małota (2860_CR21) 2019; 44 JM Kahlenberg (2860_CR26) 2013; 190 |
References_xml | – volume: 69 start-page: 148 issue: 1 year: 2017 ident: 2860_CR27 publication-title: Arthritis Rheum doi: 10.1002/art.39818 – volume: 22 start-page: 146 issue: 2 year: 2016 ident: 2860_CR37 publication-title: Nat Med doi: 10.1038/nm.4027 – volume: 107 start-page: e12 issue: 1 year: 2009 ident: 2860_CR16 publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod doi: 10.1016/j.tripleo.2008.09.015 – volume: 87 start-page: 4115 issue: 11 year: 1990 ident: 2860_CR8 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.87.11.4115 – volume: 35 start-page: 455 issue: 4 year: 2013 ident: 2860_CR18 publication-title: Semin Immunopathol doi: 10.1007/s00281-013-0375-7 – volume: 37 Suppl 118(3) start-page: 185 year: 2019 ident: 2860_CR29 publication-title: Clin Exp Rheumatol – volume: 29 start-page: 1334 issue: 11 year: 1986 ident: 2860_CR32 publication-title: Arthritis Rheum doi: 10.1002/art.1780291105 – volume: 142 start-page: 246 issue: 1 year: 2018 ident: 2860_CR20 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2017.10.030 – volume: 92 start-page: 466 issue: 4 year: 2017 ident: 2860_CR7 publication-title: An Bras Dermatol doi: 10.1590/abd1806-4841.20175476 – volume: 67 start-page: 3190 issue: 12 year: 2015 ident: 2860_CR25 publication-title: Arthritis Rheum doi: 10.1002/art.39296 – volume: 54 start-page: 2085 issue: 11 year: 2015 ident: 2860_CR3 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kev217 – ident: 2860_CR12 doi: 10.1126/sciimmunol.aag3358 – volume: 190 start-page: 1217 issue: 3 year: 2013 ident: 2860_CR26 publication-title: J Immunol doi: 10.4049/jimmunol.1202388 – volume: 59 start-page: 1752 issue: 7 year: 2020 ident: 2860_CR19 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keaa016 – volume: 10 start-page: 19629 issue: 1 year: 2020 ident: 2860_CR30 publication-title: Sci Rep doi: 10.1038/s41598-020-76701-2 – volume: 8 start-page: 883 issue: 3 year: 2014 ident: 2860_CR5 publication-title: Cell Rep doi: 10.1016/j.celrep.2014.06.044 – volume: 303 start-page: 1532 issue: 5663 year: 2004 ident: 2860_CR6 publication-title: Science doi: 10.1126/science.1092385 – volume: 15 start-page: 623 issue: 6 year: 2009 ident: 2860_CR23 publication-title: Nat Med doi: 10.1038/nm.1959 – volume: 3 start-page: 73ra19 issue: 73 year: 2011 ident: 2860_CR9 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3001180 – volume: 11 start-page: 5566 issue: 1 year: 2020 ident: 2860_CR28 publication-title: Nat Commun doi: 10.1038/s41467-020-19412-6 – volume: 77 start-page: 1825 issue: 12 year: 2018 ident: 2860_CR33 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2018-213746 – volume: 501 start-page: 273 issue: 1 year: 2018 ident: 2860_CR38 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2018.04.234 – volume: 10 start-page: 1322 issue: 1 year: 2019 ident: 2860_CR40 publication-title: Nat Commun doi: 10.1038/s41467-019-09160-7 – volume: 24 start-page: 6690 issue: 12 year: 2020 ident: 2860_CR39 publication-title: J Cell Mol Med doi: 10.1111/jcmm.15321 – volume: 187 start-page: 538 issue: 1 year: 2011 ident: 2860_CR1 publication-title: J Immunol doi: 10.4049/jimmunol.1100450 – volume: 7 start-page: 829 issue: 12 year: 2015 ident: 2860_CR41 publication-title: World J Cardiol doi: 10.4330/wjc.v7.i12.829 – volume: 5 start-page: 178ra140 issue: 178 year: 2013 ident: 2860_CR2 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3005580 – volume: 61 start-page: 554 issue: 6 year: 2002 ident: 2860_CR14 publication-title: Ann Rheum Dis doi: 10.1136/ard.61.6.554 – volume: 1 issue: 1 year: 2015 ident: 2860_CR15 publication-title: RMD Open doi: 10.1136/rmdopen-2014-000022 – volume: 7 start-page: 113 issue: 1 year: 2021 ident: 2860_CR17 publication-title: Cell Death Dis doi: 10.1038/s41420-021-00491-3 – volume: 18 start-page: 320 issue: 7 year: 1997 ident: 2860_CR10 publication-title: Immunol Today doi: 10.1016/S0167-5699(97)01087-6 – volume: 44 start-page: 111 year: 2019 ident: 2860_CR21 publication-title: Mitochondrion doi: 10.1016/j.mito.2018.01.007 – volume: 79 start-page: 1468 issue: 11 year: 2020 ident: 2860_CR31 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2019-216588 – volume: 184 start-page: 3284 issue: 6 year: 2010 ident: 2860_CR36 publication-title: J Immunol doi: 10.4049/jimmunol.0902199 – volume: 14 start-page: 467 issue: 8 year: 2018 ident: 2860_CR4 publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-018-0039-z – volume: 98 start-page: 122 year: 2019 ident: 2860_CR24 publication-title: J Autoimmun doi: 10.1016/j.jaut.2019.01.003 – volume: 187 start-page: 490 issue: 1 year: 2011 ident: 2860_CR35 publication-title: J Immunol doi: 10.4049/jimmunol.1100123 – volume: 207 start-page: 1853 issue: 9 year: 2010 ident: 2860_CR11 publication-title: J Exp Med doi: 10.1084/jem.20100239 – volume: 7 start-page: 691 issue: 12 year: 2011 ident: 2860_CR22 publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2011.132 – volume: 366 start-page: 321 issue: 9482 year: 2005 ident: 2860_CR13 publication-title: Lancet doi: 10.1016/S0140-6736(05)66990-5 – ident: 2860_CR34 doi: 10.1172/jci.insight.134189 |
SSID | ssj0022924 |
Score | 2.545966 |
Snippet | Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's... Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome... Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren’s... Abstract Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 1 |
SubjectTerms | Analysis Antibodies Arthritis Autoimmune diseases Biological response modifiers Care and treatment Cell culture Diagnosis Disease Flow cytometry Gene expression Granulocytes Health aspects Hospitals Interferon Medical research Mitochondrial damage Neutrophil extracellular traps Neutrophils Pathogenesis Pathogens Plasma Primary Sjögren’s syndrome Reactive oxygen species Sjogren's syndrome Type I interferon |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagSIgL4lcsFGQkJEDIan7sxD6hgloVpPZCK-3Nsh2n3apKQpLlzGtw4DV4Ad6EJ2HG6902IPWwUnY9jtea8fgbe34IeSUqLBYtE1ZzKxm3zjElKs9MqYxzFiBqjbHDh0fFwQn_PBfzeOA2RLfKtU4MirpqHZ6R72QF3hGDyIn33VeGVaPwdjWW0LhJbmHqMpTqcn5pcGVqVdSWg6UEGytfB83IYmcA3V1ibHIGH1kkjE82ppC__38t_a_n5JWtaP8euRsxJN1dMf0-ueGbB-T2Ybwlf0h-Au9p147oCAR06EA40LameNxKP1HMENHXvm8bilEN3wBtVrTxy7Fvu7PFxUBNc_U7BfXdGzzgR49VCs_dQN8c7R0Pb-FVdMSxAEa2p6g1F2GgbpXCgn45__0L7Pnmz_cfA13nRnhETvb3jj8esFiGgTmwbkZmc0QRygjrcjDmMl8DyjOSK9j7jE2l9B4DZAvMKarAHOWmKrmolaxVBfpA5Y_JVtM2_gmhwsokN6m1oqy4k7kpstIlVlRVYQQv-Yykax5oF3OUY6mMCx1sFVnoFd808E0Hvmno827TJ07vWuoPyNoNJWbXDj-0_amOixUAhLMKNJtKDQAseLZpoaSFf-sA0KVuRl6jYGjUAcgBE0MZYJKYTUvvAmwDQzRL8hnZnlDC2nXT5rVo6ag7Bn0p6TPyctOMPdEfrvHtMtBkmNkugQmVE5GczGza0izOQv5wQMQiE_Lp9YM_I3eysDxKlqptsjX2S_8cANhoX4RV9hcy1zCS priority: 102 providerName: ProQuest |
Title | The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren’s syndrome |
URI | https://www.proquest.com/docview/2691340405 https://www.proquest.com/docview/2692072104 https://pubmed.ncbi.nlm.nih.gov/PMC9295258 https://doaj.org/article/bacb948891a743cb9b1698ba62c6391c |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ditNAFB50BfFG_MXqWkYQVCRsfmYyM5dd6bIKW0S30LthZjLZrSxJSVKvfQ0vfA1fwDfxSTwnP6VR0BsvWtLOmaST85-e8w0hz3mGm0XLMMiZlQGzzgWKZz4wQhnnLISoOfYOny3S0yV7t-Krva2-sCasgwfubtyRNc4qkDIVGXB2cGyjVElr0tiBc40cWl_weUMy1adaMaQVQ4uMTI9qsNQCO5FjeMk0DNjIDbVo_X_a5N_rJPccz8kdcruPGOms-6V3yTVf3CM3z_r_xO-Tb8BpuikbLPsBOiwXrGmZU3y4St9SxIOocl-VBcUehs8QW2a08NumKjeX66uammL_MwVjXRl8nI_1qRSONzV9uZif16_gVLTBa0HQWF6gjVy3F9p0gBX046cf3yF7L35--VrTAQnhAVmezM_fnAb9pguBg1ymCWyCMYMy3LoEUrfY5xDTGckUeDpjIym9x3bYFBFEFSSfzGSC8VzJXGWg_Sp5SA6KsvCPCOVWhomJrOUiY04mwDPhQsuzLDWcCTYh0cAD7XpEctwY40q3mYlMdcc3DXzTLd80zHm9m9Mv76_Ux8jaHSViabdfgITpXsL0vyRsQl6gYGjUeOSA6RsXYJGInaVnEKRB2hmHyYQcjihBU914eBAt3VuKWscp1j6AKeUT8mw3jDOx-q3w5baliRHHLoQFiZFIjlY2HinWly1aOMS_POby8f-4FU_IrbhVIhFE6pAcNNXWP4WgrLFTcl2sxJTcOJ4v3n-YttoI78t49guSCDrO |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqIgEXxK_YUsBIIEAoapK1E_uAUIFWu7S7F7bS3oztONtFVbIkWRA3XoMDr8CRF-BNeBJmssm2Aam3HiIlaztea8Yz38TzQ8hjnmCxaOF7KTPCY8ZaT_LEeTqW2loDEDXF2OHROBocsXdTPt0gP9tYGHSrbGViLaiT3OI38p0wwjNiYDn-avHJw6pReLraltBYscWB-_oFTLby5fAt0PdJGO7vTd4MvKaqgGcBrFee6aNSlJob2wfbJHQpgBYtmARRrk0ghHMY7xlhikwJ1hXTScx4KkUqE2BvTL4EIv8SKF4fjb14emrghXJVRJeBZQaKnLVBOiLaKUFXxBgLHcIlIt9jHUVY1wv4Xyv866l5RvXtXyfXGsxKd1dMdoNsuOwmuTxqTuVvkR_Aa3SRV-h4BP3QYbGkeUrx8y4dUsxIUaSuyDOKURSfAd0mNHPLqsgXx_OTkurs7DMFdVFoPFBAD1kK94uSPhvvTcrn8Cpa4VwAW_MZSul5PdFilTKDvv_4-9escNmfb99L2uZiuE2OLoRAd8hmlmfuLqHcCL-vA2N4nDAr-joKY-sbniSR5ixmPRK0NFC2yYmOpTlOVG0biUit6KaAbqqmm4IxL9ZjmuWd2_s1knbdE7N51z_kxUw1wgEAizUSJKkMNAA6uDdBJIWBf2sBQAa2R54iYyiUOUgB3YROwCIxe5faBZgIhm_o93tku9MTZIXtNrespRpZVarTndUjj9bNOBL97zKXL-s-IWbS82FBcYclOyvrtmTz4zpfOSBwHnKxdf7kD8mVwWR0qA6H44N75GpYb5XYC-Q22ayKpbsP4K8yD-odR8mHi97ifwEPqWqH |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+potential+roles+of+type+I+interferon+activated+neutrophils+and+neutrophil+extracellular+traps+in+the+pathogenesis+of+primary+Sj%C3%B6gren%27s+syndrome&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Peng%2C+Yu&rft.au=Wu%2C+Xunyao&rft.au=Zhang%2C+Shulan&rft.au=Deng%2C+Chuiwen&rft.date=2022-07-19&rft.pub=BioMed+Central+Ltd&rft.issn=1478-6354&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs13075-022-02860-4&rft.externalDocID=A710871203 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon |